Federal award
ASTRAZENECA PHARMACEUTICALS LP
W911QY20C0119
Contract
Obligated and Ceiling
- Obligated (net)
- $1,107,934,203.08
- Ceiling (potential value, not spending)
- $1,107,934,203.08
- Current value
- $1,107,934,203.08
- Gross positive obligations
- $1,107,968,000.00
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- ASTRAZENECA PHARMACEUTICALS LP · E5K2ZJ8CTJH4
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- ASTRAZENECA PLC · G2FBBTMF9F24
- Awarding agency
- Department of War · sub-agency 2100 · office W58P05
- Funding agency
- Department of War · sub-agency 2100
- Product or service (PSC)
- 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
- Industry (NAICS)
- 325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
- PIID
- W911QY20C0119
- Award type code
- D
- Actions
- 12 · Sep 30, 2020 to Aug 3, 2023
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History12
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Aug 3, 2023 | FY2023 | P00010 | C | −$33,796.92 | — |
| Mar 23, 2023 | FY2023 | P00009 | B | $0.00 | — |
| May 12, 2022 | FY2022 | P00008 | M | $0.00 | — |
| Apr 28, 2022 | FY2022 | P00007 | B | $1,132,000.00 | — |
| Apr 4, 2022 | FY2022 | P00006 | D | $0.00 | — |
| Feb 11, 2022 | FY2022 | P00005 | A | $855,000,000.00 | — |
| Jan 3, 2022 | FY2022 | P00004 | B | $6,870,000.00 | — |
| Nov 22, 2021 | FY2022 | P00003 | B | $0.00 | — |
| May 7, 2021 | FY2021 | P00002 | M | $0.00 | — |
| Mar 8, 2021 | FY2021 | P00001 | B | $204,880,000.00 | — |
| Jan 8, 2021 | FY2021 | PZ0001 | H | $10,086,000.00 | — |
| Sep 30, 2020 | FY2020 | 0 | — | $30,000,000.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.